BPH Global Limited (ASX:BP8) Releases Quarterly Activities Report and Secures Funding
BPH Global Limited (ASX:BP8) releases Q1 2025 report, secures $609K funding, and advances Indonesian seaweed projects.
ImpediMed Limited (ASX:IPD) Announces Q3 Revenue and ARR Growth
ImpediMed Limited (ASX:IPD) reports record Q3 revenue and ARR growth, along with key operational and management developments.
Wisr (ASX:WZR) Upgrades FY25 Guidance with Strong Q3 Results
Wisr (ASX:WZR) upgrades FY25 loan origination growth guidance to over 90%, reporting strong Q3FY25 financial performance and improved loan book quality.
Origin Energy Limited (ASX:ORG) Releases March 2025 Quarterly Report
Origin Energy (ASX:ORG) releases its March 2025 Quarterly Report, highlighting financial performance, renewable investments, and significant growth in Octopus Energy.
Coles Group Limited (ASX:COL) Announces Third Quarter Sales Results
Coles Group Limited (ASX:COL) reports a 3.4% increase in Q3 2025 sales revenue, driven by strong performance in supermarkets and liquor segments.
Appen Limited (ASX:APX) Releases Q1 FY25 Performance Report
Appen Limited (ASX:APX) reports Q1 FY25 revenue of $50.2M, improved EBITDA loss, and a strong cash position.
Sparc Technologies Limited (ASX: SPN) Releases March 2025 Quarterly Report
Sparc Technologies Limited (ASX: SPN) releases its March 2025 Quarterly Report, highlighting advancements in green hydrogen and graphene-based additives alongside key corporate and financial updates.
Ionic Rare Earths (ASX: IXR) Advances Magnet Recycling and REE Projects
Ionic Rare Earths (ASX: IXR) reports significant progress in magnet recycling and heavy rare earth projects, reducing CO₂ emissions.
Electro Optics Systems Holdings (ASX:EOS) Reports Business Turnaround and Financial Strengthening
EOS (ASX:EOS) announces significant business restructuring, portfolio divestments, and financial repayments as part of its ongoing turnaround strategy.
Mesoblast Limited (ASX:MSB) Announces Q3 2025 Highlights
Mesoblast Limited (ASX:MSB) reports Q1 2025 milestones, including the US launch of Ryoncil® and strong financial performance.